Table 2.
Subjective cognitive decline (SCD) | Mild cognitive impairment (MCI) | |||||||
---|---|---|---|---|---|---|---|---|
Men | Women | Men | Women | |||||
Aβ/P-tau+ | Aβ/P-tau− | Aβ/P-tau+ | Aβ/P-tau− | Aβ/P-tau+ | Aβ/P-tau− | Aβ/P-tau+ | Aβ/P-tau− | |
(N = 34) | (N = 51) | (N = 25) | (N = 76) | (N = 74) | (N = 75) | (N = 63) | (N = 34) | |
Age | 72.59 (5.37) a,b | 70.22 (5.46) a,b | 70.63 (4.84) a,b | 69.78 (5.69) a,b | 72.35 (5.13) a | 69.59 (5.74) a | 71.37 (4.88) a | 69.76 (5.52) a |
Education | 11.71 (3.84) a | 13.00 (3.59) a | 11.60 (3.33) a | 11.97 (3.30) a | 11.62 (3.49) a | 10.71 (3.48) a | 11.44 (3.07) a | 10.47 (3.13) a |
ADAS Delayed Word Recall Omissions (/10) | 4.12 (1.89) | 3.38 (1.89) | 5.06 (3.02) | 4.73 (2.80) | 6.91 (2.06) a | 5.92 (2.10) a | 7.43 (1.81) a | 5.24 (2.69) a |
MMSE total score | 28.35 (1.54) | 28.92 (1.29) | 27.88 (1.88) | 27.74 (1.73) | 26.65 (1.67) | 27.56 (1.85) | 26.84 (1.79) | 27.62 (1.88) |
Total intracranial volume | 1.7 × 106 (1.1 × 105) | 1.7 × 106 (1.3 × 105) | 1.5 × 106 (1.1 × 105) | 1.5 × 106 (1.2 × 105) | 1.7 × 106 (1.3 × 105) | 1.7 × 106 (1.4 × 105) | 1.5 × 106 (1.2 × 105) | 1.5 × 106 (1.2 × 105) |
Total hippocampal volume | 7.2 × 103 (1.1 × 103) | 7.7 × 103 (1.3 × 103) | 6.8 × 103 (1.3 × 103) | 6.7 × 103 (1.1 × 103) | 6.7 × 103 (1.1 × 103) | 7.2 × 103 (1.3 × 103) | 6.1 × 103 (1.0 × 103) | 6.6 × 103 (1.2 × 103) |
APOE ε4 carriers | 21 a | 14 a | 17 a | 21 a | 55 a | 20 a | 46 a | 6 a |
Abbreviations: Aβ/P-tau+ amyloid beta/P-tau positive, ADAS Alzheimer’s Disease Assessment Scale, APOE apolipoprotein E, MMSE Mini-Mental State Examination
aDiffers by Aβ/P-tau+ within diagnostic group, p < 0.05
bDiffers by sex within diagnostic group, p < 0.05
Significant differences in these variables by Aβ/P-tau status and sex within each diagnostic group are indicated by superscript